Indeed, the present data suggested that both the expression levels of PAI-1 on melanoma cells and serum PAI-1 levels were significantly correlated with the efficacy of anti-PD1 Abs in advanced melanoma patients. The gene discussed is SERPINE1; the disease is melanoma.